Reducing LDL cholesterol and ApoB is essential to optimize long-term health and extend lifespan.

noli's read

The idea that ApoB-containing lipoproteins (including LDL) are causal factors in atherosclerosis is widely supported by the current scientific consensus. Meta-analyses of Mendelian randomization studies and randomized controlled trials (RCTs), such as those cited by Dr. Peter Attia, confirm that prolonged exposure to high levels of ApoB linearly increases cardiovascular risk. The advice is biologically sound, as reducing these markers effectively decreases plaque formation in the arteries. What might be considered an extrapolation is the claim that this guarantees increased 'longevity,' as longevity depends on numerous other factors (genetics, inflammation, and other chronic diseases). The strategies proposed to achieve this (diet, exercise, treatments) are validated, although the intensity required to reach very low levels remains a subject of clinical debate. In short, the approach is well-grounded in modern cardiovascular prevention.

the sources

No named source held this one up — that absence is part of the verdict.